Back to Search Start Over

European Respiratory Society statement on long COVID follow-up

Authors :
Katerina M. Antoniou
Eirini Vasarmidi
Anne-Marie Russell
Claire Andrejak
Bruno Crestani
Marion Delcroix
Anh Tuan Dinh-Xuan
Venerino Poletti
Nicola Sverzellati
Michele Vitacca
Martin Witzenrath
Thomy Tonia
Antonio Spanevello
DESSAIVRE, Louise
University of Crete [Heraklion] (UOC)
Physiopathologie et Epidémiologie des Maladies Respiratoires (PHERE (UMR_S_1152 / U1152))
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
University of Exeter Medical School
University of Exeter
Agents infectieux, résistance et chimiothérapie - UR UPJV 4294 (AGIR )
Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie
CHU Amiens-Picardie
AP-HP - Hôpital Bichat - Claude Bernard [Paris]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
University Hospitals Leuven [Leuven]
Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven)
Hôpital Cochin [AP-HP]
G.B. Morgagni-Pierantoni Hospital [Forlì, Italy]
Aarhus University Hospital
Università degli studi di Parma = University of Parma (UNIPR)
Istituti Clinici Scientifici Maugeri IRCCS [Brescia]
Charité - UniversitätsMedizin = Charité - University Hospital [Berlin]
University of Bern
Universitá degli Studi dell’Insubria = University of Insubria [Varese] (Uninsubria)
Source :
European Respiratory Journal, European Respiratory Journal, 2022, 60 (2), ⟨10.1183/13993003.02174-2021⟩, Antoniou, K M, Vasarmidi, E, Russell, A M, Andrejak, C, Crestani, B, Delcroix, M, Dinh-Xuan, A T, Poletti, V, Sverzellati, N, Vitacca, M, Witzenrath, M, Tonia, T & Spanevello, A 2022, ' European Respiratory Society statement on long COVID follow-up ', European Respiratory Journal, vol. 60, no. 2, 2102174 . https://doi.org/10.1183/13993003.02174-2021
Publication Year :
2022
Publisher :
EUROPEAN RESPIRATORY SOC JOURNALS LTD, 2022.

Abstract

Patients diagnosed with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection frequently experience symptom burden post-acute infection or post-hospitalisation. We aimed to identify optimal strategies for follow-up care that may positively impact the patient's quality of life (QoL). A European Respiratory Society (ERS) Task Force convened and prioritised eight clinical questions. A targeted search of the literature defined the timeline of "long COVID" as 1-6 months post-infection and identified clinical evidence in the follow-up of patients. Studies meeting the inclusion criteria report an association of characteristics of acute infection with persistent symptoms, thromboembolic events in the follow-up period, and evaluations of pulmonary physiology and imaging. Importantly, this statement reviews QoL consequences, symptom burden, disability and home care follow-up. Overall, the evidence for follow-up care for patients with long COVID is limited. ispartof: EUROPEAN RESPIRATORY JOURNAL vol:60 issue:2 ispartof: location:England status: published

Details

Language :
English
ISSN :
09031936 and 13993003
Database :
OpenAIRE
Journal :
European Respiratory Journal, European Respiratory Journal, 2022, 60 (2), ⟨10.1183/13993003.02174-2021⟩, Antoniou, K M, Vasarmidi, E, Russell, A M, Andrejak, C, Crestani, B, Delcroix, M, Dinh-Xuan, A T, Poletti, V, Sverzellati, N, Vitacca, M, Witzenrath, M, Tonia, T & Spanevello, A 2022, ' European Respiratory Society statement on long COVID follow-up ', European Respiratory Journal, vol. 60, no. 2, 2102174 . https://doi.org/10.1183/13993003.02174-2021
Accession number :
edsair.doi.dedup.....0adb67e8856fc801f070dc24226f94ae